Cargando…
Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries
Background: Pancreatic ductal adenocarcinoma (PDAC) is a type of lethal gastrointestinal malignancy. It is mainly discovered at, and diagnosed with, an advanced stage of metastasis. As the only potentially curative treatment for PDAC, surgical resection has an uncertain impact on the survival of the...
Autores principales: | Li, Zheng, Zhang, Xiaojie, Sun, Chongyuan, Li, Zefeng, Fei, He, Zhao, Dongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867229/ https://www.ncbi.nlm.nih.gov/pubmed/36675442 http://dx.doi.org/10.3390/jcm12020513 |
Ejemplares similares
-
Effects of Serum Lipids on the Long-Term Prognosis of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Li, Zheng, et al.
Publicado: (2022) -
Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review
por: Halle-Smith, James M, et al.
Publicado: (2023) -
Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study
por: Kandel, Pujan, et al.
Publicado: (2018) -
Impact of Diabetes on Short-Term and Long-Term Outcomes of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Zhang, Xiaojie, et al.
Publicado: (2022) -
Primary tumor resection and lymph node dissection improve survival in de novo metastatic pancreatic ductal adenocarcinoma: an inverse probability of treatment weighting analysis
por: Wu, Chaorui, et al.
Publicado: (2020)